Skip to main content
Premium Trial:

Request an Annual Quote

Mitsubishi To Sell Waban Software in Japan

NEW YORK (GenomeWeb News) - Mitsubishi Space Software will sell Waban Software’s Waban Explorer PGx and Waban SCE in Japan, the companies said today.
 
Financial terms of the deal were not disclosed.
 
In a statement, Himanshu Oberoi, president of Waban, said the deal grew out of the global growth of clinical pharmacogenomics, biomarker development and personalized medicine and the increased demand in Asia for Waban products.
 
Waban Explorer PGx provides a secure, 21 CFR11-compliant platform for integrating multiple data sources “and enables exploring, browsing, querying and running analyses using multiple analysis tools,” the company said.
 
Waban SCE offers a controlled environment for managing analyses and reporting in a 21 CFR11-compliant manner with a full audit trail and traceability, Waban added.

Filed under

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.